HUE062554T2 - Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás - Google Patents

Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás

Info

Publication number
HUE062554T2
HUE062554T2 HUE21190088A HUE21190088A HUE062554T2 HU E062554 T2 HUE062554 T2 HU E062554T2 HU E21190088 A HUE21190088 A HU E21190088A HU E21190088 A HUE21190088 A HU E21190088A HU E062554 T2 HUE062554 T2 HU E062554T2
Authority
HU
Hungary
Prior art keywords
pcta
gadolinium
complex
preparation
purification process
Prior art date
Application number
HUE21190088A
Other languages
English (en)
Hungarian (hu)
Inventor
Greneur Soizic Le
Alain Chenede
Martine Cerf
Myriam Petta
Emmanuelle Marais
Bruno François
Caroline Robic
Stephanie Louguet
Original Assignee
Guerbet Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guerbet Sa filed Critical Guerbet Sa
Publication of HUE062554T2 publication Critical patent/HUE062554T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/003Compounds containing elements of Groups 3 or 13 of the Periodic Table without C-Metal linkages
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00Preparations for testing in vivo
    • A61K49/06Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10Organic compounds
    • A61K49/101Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/106Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HUE21190088A 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás HUE062554T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1900432A FR3091873B1 (fr) 2019-01-17 2019-01-17 Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification

Publications (1)

Publication Number Publication Date
HUE062554T2 true HUE062554T2 (hu) 2023-11-28

Family

ID=67001953

Family Applications (2)

Application Number Title Priority Date Filing Date
HUE21190088A HUE062554T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás
HUE20701709A HUE060343T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárása

Family Applications After (1)

Application Number Title Priority Date Filing Date
HUE20701709A HUE060343T2 (hu) 2019-01-17 2020-01-17 Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárása

Country Status (28)

Country Link
US (3) US11590246B2 (https=)
EP (2) EP3902800B1 (https=)
JP (2) JP7071596B2 (https=)
KR (2) KR102438394B1 (https=)
CN (3) CN113646308B (https=)
AR (1) AR117835A1 (https=)
AU (1) AU2020208794B2 (https=)
BR (1) BR112021014006B1 (https=)
CA (1) CA3126268C (https=)
CL (1) CL2021001868A1 (https=)
CO (1) CO2021009261A2 (https=)
DK (2) DK3943493T3 (https=)
ES (2) ES2930136T3 (https=)
FI (1) FI3943493T3 (https=)
FR (1) FR3091873B1 (https=)
HR (2) HRP20230678T1 (https=)
HU (2) HUE062554T2 (https=)
IL (1) IL284884B2 (https=)
MA (2) MA54626A (https=)
MX (1) MX2021008651A (https=)
PH (1) PH12021551725A1 (https=)
PL (2) PL3943493T3 (https=)
PT (2) PT3943493T (https=)
RS (1) RS64334B1 (https=)
SG (1) SG11202107779SA (https=)
TW (1) TWI811518B (https=)
WO (1) WO2020148436A1 (https=)
ZA (1) ZA202104994B (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT4151637T (pt) 2018-08-06 2025-03-26 Bracco Imaging Spa Agentes de contraste à base de pcta que suportam gadolínio
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese
KR20230041007A (ko) * 2020-07-17 2023-03-23 게르브 Pcta로부터 유도된 킬레이팅 리간드의 제조 방법
KR20230074593A (ko) * 2020-10-02 2023-05-30 이글 하버 테크놀로지스, 인코포레이티드 이온 전류 드룹 보상
WO2024049087A1 (ko) * 2022-09-01 2024-03-07 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
KR102845061B1 (ko) * 2022-09-01 2025-08-13 주식회사 테라노큐어 신규한 화합물 및 이를 포함하는 mri 조영제
WO2026027591A1 (en) 2024-07-31 2026-02-05 Bracco Imaging Spa Synthesis of an intermediate of a gadolinium-based contrast agent

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647447A (en) 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
DE3640708C2 (de) 1986-11-28 1995-05-18 Schering Ag Verbesserte metallhaltige Pharmazeutika
DE4001655A1 (de) 1990-01-18 1991-07-25 Schering Ag 6-ring enthaltende makrocyclische tetraaza-verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel
JPH04154729A (ja) 1990-10-16 1992-05-27 Nippon Mejifuijitsukusu Kk 磁気共鳴造影剤
IT1292128B1 (it) 1997-06-11 1999-01-25 Bracco Spa Processo per la preparazione di chelanti macrociclici e loro chelati con ioni metallici paramagnetici
EP0992245A1 (en) 1998-09-16 2000-04-12 Goldham Bioglan Pharma GmbH Radio-contrast agents
FR2793795B1 (fr) * 1999-05-21 2001-08-03 Guerbet Sa Isomeres de tetramides du complexe de gadolinium de l'acide (1,4,7,10-tetrazacyclododecane)1,4,7,10-tetra(2-glutarique) leur procede de preparation et leur application en imagerie medicale
FR2794744B1 (fr) 1999-06-09 2001-09-21 Guerbet Sa Complexes metalliques de polyaminoacides bicycliques, leur procede de preparation et leur application en imagerie medicale
FR2891830B1 (fr) 2005-10-07 2011-06-24 Guerbet Sa Composes a chaines aminoalcools courtes et complexes metalliques pour l'imagerie medicale
US20090208421A1 (en) * 2008-02-19 2009-08-20 Dominique Meyer Process for preparing a pharmaceutical formulation of contrast agents
US8119817B2 (en) * 2009-09-29 2012-02-21 Degussa-Huels Ag Process for separating the diastereomers of RSS-and SSS-N- α [1-carboxy-3-phenylpropyl] lysylproline
EP2786768A1 (en) 2013-04-04 2014-10-08 Agfa Healthcare Process for preparing a material comprising a macrocyclic ligand and for producing a pharmaceutical formulation comprising said ligand with a lanthanide
CN105142649A (zh) * 2013-04-26 2015-12-09 法国加柏公司 造影剂配制品与有关制备方法
CN104188957B (zh) * 2014-05-28 2017-04-26 中国中医科学院西苑医院 一种防治再狭窄的药物及其制备和使用方法
WO2018199040A1 (ja) * 2017-04-28 2018-11-01 株式会社大塚製薬工場 クエン酸誘導体のジアステレオマーの製造方法
PT4151637T (pt) * 2018-08-06 2025-03-26 Bracco Imaging Spa Agentes de contraste à base de pcta que suportam gadolínio
FR3091873B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de preparation et de purification
FR3091872B1 (fr) * 2019-01-17 2020-12-25 Guerbet Sa Complexe de gadolinium et d’un ligand chelateur derive de pcta diastereoisomeriquement enrichi et procede de synthese

Also Published As

Publication number Publication date
AU2020208794A1 (en) 2021-08-05
US20230149568A1 (en) 2023-05-18
KR102502862B1 (ko) 2023-02-23
WO2020148436A1 (fr) 2020-07-23
TWI811518B (zh) 2023-08-11
PT3943493T (pt) 2023-07-12
HUE060343T2 (hu) 2023-02-28
HRP20230678T1 (hr) 2023-09-29
CN113735854B (zh) 2024-05-14
FI3943493T3 (fi) 2023-07-19
CN113646308B (zh) 2024-12-13
MA55389A (fr) 2022-01-26
FR3091873B1 (fr) 2020-12-25
IL284884B2 (en) 2025-09-01
US12064487B2 (en) 2024-08-20
BR112021014006A2 (pt) 2021-09-21
CN113735854A (zh) 2021-12-03
EP3902800A1 (fr) 2021-11-03
CL2021001868A1 (es) 2022-01-21
HRP20221402T1 (hr) 2023-01-06
JP2022508496A (ja) 2022-01-19
KR102438394B1 (ko) 2022-09-01
ES2930136T3 (es) 2022-12-07
CO2021009261A2 (es) 2021-12-10
AR117835A1 (es) 2021-08-25
CA3126268A1 (fr) 2020-07-23
KR20210138134A (ko) 2021-11-18
PH12021551725A1 (en) 2022-04-11
US20240358863A1 (en) 2024-10-31
DK3943493T3 (da) 2023-07-24
ES2950118T3 (es) 2023-10-05
JP2022009463A (ja) 2022-01-14
TW202043227A (zh) 2020-12-01
PL3902800T3 (pl) 2022-12-27
EP3943493A1 (fr) 2022-01-26
JP7071596B2 (ja) 2022-05-19
JP7321230B2 (ja) 2023-08-04
MA54626A (fr) 2022-04-20
SG11202107779SA (en) 2021-08-30
PL3943493T3 (pl) 2023-08-07
RS64334B1 (sr) 2023-08-31
CN119552163A (zh) 2025-03-04
MX2021008651A (es) 2021-10-26
PT3902800T (pt) 2022-11-16
US20220062443A1 (en) 2022-03-03
FR3091873A1 (fr) 2020-07-24
AU2020208794B2 (en) 2023-01-12
EP3943493B1 (fr) 2023-04-19
IL284884A (en) 2021-08-31
DK3902800T3 (da) 2022-11-28
KR20210109039A (ko) 2021-09-03
CN113646308A (zh) 2021-11-12
ZA202104994B (en) 2023-04-26
BR112021014006B1 (pt) 2023-05-02
EP3902800B1 (fr) 2022-09-07
IL284884B1 (en) 2025-05-01
CA3126268C (fr) 2024-01-09
US11590246B2 (en) 2023-02-28

Similar Documents

Publication Publication Date Title
HUE062554T2 (hu) Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási és tisztítási eljárás
HUE060073T2 (hu) Gadolínium és egy diasztereomeresen dúsított PCTA-ból származó kelátképzõ ligandum komplexe, és elõállítási eljárása
MX2023001234A (es) Anticuerpos anti-cd71, anticuerpos anti-cd71 activables, y metodos de uso de los mismos.
HUE043743T2 (hu) Reaktív gázt elõállító rendszer és kezelõeljárás reaktív gáz alkalmazásával
GB2587072B (en) Large-scale preparation process of highly stable adsorbent for removing cesium, the resulting adsorbent and use thereof
DK4108769T3 (da) Fremgangsmåde til fremstilling og oprensning af rna, omfattende mindst et trin til tangential-flow-filtrering
EP3825292A4 (en) Complex oxide ceramic, method for producing same, and article
ZA201807828B (en) 99m tc-edda/hynic-ipsma as a radiopharmaceutical for detecting the overexpression of prostate-specific membrane antigen
HUE045906T2 (hu) Új szulfonimidoilpurinon vegyületek és származékok vírusfertõzés kezelésére és megelõzésére
EP3804853A4 (en) PROCESS FOR MANUFACTURING S-INDOXACARB
IL283453A (en) Dry powder inhalation formulation and its use for the therapeutic treatment of lungs
GB2616179B (en) Bassinet
ZA202005510B (en) A process for enterovirus purification and inactivation and vaccine compositions obtained thereof
EP3649247A4 (en) PURIFICATION OF POLYSACCHARIDES FOR VACCINE PRODUCTION USING LYTIC ENZYMES, TANGENTIAL FILTRATION AND MULTIMODAL CHROMATOGRAPHY
EP3957622A4 (en) PROCEDURE FOR PURIFICATION OF 1,2-DIFLUORETHYLENE (HFO-1132)
DK3448554T3 (da) Korrosionsbestandig, reaktiv absorbent til behandling af kontamineret vand, fremgangsmåde til fremstilling af samme, og dens anvendelse
EP4073049A4 (en) NEW CRYSTALLINE FORMS OF FLUFENACET, METHOD FOR THEIR PRODUCTION AND THEIR USE
EP4048188C0 (en) TEETH WHITENING SYSTEM
SG11202105807XA (en) Process for the preparation of a cyclic dinucleotide
PT3514235T (pt) Composição para o tratamento de um doente que sofre de colite ulcerosa, assim como utilização da composição como medicamento
SG11202107799XA (en) Enriched water formulations and processes for preparation thereof
EP4009975A4 (en) Compounds for hepatitis b treatment
UA73063U (ru) Способ восстановления дефектов зубных рядов частичными съемными протезами с помощью применения гибких кламмеров из полиоксиметилена
CA191533S (en) Jewellery ring stretcher
GB201911849D0 (en) Trackuino programmer & debugger